235 related articles for article (PubMed ID: 11885931)
21. Modified vaccinia virus Ankara as a vector for suicide gene therapy.
Erbs P; Findeli A; Kintz J; Cordier P; Hoffmann C; Geist M; Balloul JM
Cancer Gene Ther; 2008 Jan; 15(1):18-28. PubMed ID: 17992203
[TBL] [Abstract][Full Text] [Related]
22. Construction and isolation of recombinant MVA.
Staib C; Drexler I; Sutter G
Methods Mol Biol; 2004; 269():77-100. PubMed ID: 15114009
[TBL] [Abstract][Full Text] [Related]
23. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.
Wyatt LS; Earl PL; Eller LA; Moss B
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4590-5. PubMed ID: 15070762
[TBL] [Abstract][Full Text] [Related]
24. [Construction and biological characteristic for the recombinant modified vaccinia virus ankara co-expressing modified GP5 and M protein of porcine reproductive and respiratory syndrome virus].
Zheng Q; Li P; Cao R; Hou J; Chen P
Sheng Wu Gong Cheng Xue Bao; 2008 May; 24(5):766-73. PubMed ID: 18724695
[TBL] [Abstract][Full Text] [Related]
25. Easy and efficient protocols for working with recombinant vaccinia virus MVA.
Kremer M; Volz A; Kreijtz JH; Fux R; Lehmann MH; Sutter G
Methods Mol Biol; 2012; 890():59-92. PubMed ID: 22688761
[TBL] [Abstract][Full Text] [Related]
26. A vaccinia virus vector for efficiently introducing into hippocampal slices.
Ozaki M; Matsumura K; Kaneko S; Satoh M; Watanabe Y; Aoyama T
Biochem Biophys Res Commun; 1993 Jun; 193(2):653-60. PubMed ID: 8512565
[TBL] [Abstract][Full Text] [Related]
27. Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.
Kreijtz JH; Suezer Y; de Mutsert G; van den Brand JM; van Amerongen G; Schnierle BS; Kuiken T; Fouchier RA; Löwer J; Osterhaus AD; Sutter G; Rimmelzwaan GF
J Infect Dis; 2009 Feb; 199(3):405-13. PubMed ID: 19061423
[TBL] [Abstract][Full Text] [Related]
28. [Modified vaccinia virus ankara (MVA)--development as recombinant vaccine and prospects for use in veterinary medicine].
Volz A; Fux R; Langenmayer MC; Sutter G
Berl Munch Tierarztl Wochenschr; 2015; 128(11-12):464-72. PubMed ID: 26697713
[TBL] [Abstract][Full Text] [Related]
29. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
30. Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection.
Di Lullo G; Soprana E; Panigada M; Palini A; Erfle V; Staib C; Sutter G; Siccardi AG
J Virol Methods; 2009 Mar; 156(1-2):37-43. PubMed ID: 19038289
[TBL] [Abstract][Full Text] [Related]
31. Expression of feline immunodeficiency virus (FIV) gag gene in vaccinia virus vector.
Wojcik J
Acta Microbiol Pol; 1995; 44(2):191-6. PubMed ID: 8906935
[TBL] [Abstract][Full Text] [Related]
32. Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.
Kreijtz JH; Suezer Y; van Amerongen G; de Mutsert G; Schnierle BS; Wood JM; Kuiken T; Fouchier RA; Lower J; Osterhaus AD; Sutter G; Rimmelzwaan GF
J Infect Dis; 2007 Jun; 195(11):1598-606. PubMed ID: 17471429
[TBL] [Abstract][Full Text] [Related]
33. Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virus.
Sutter G; Moss B
Dev Biol Stand; 1995; 84():195-200. PubMed ID: 7796954
[No Abstract] [Full Text] [Related]
34. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I
J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
[TBL] [Abstract][Full Text] [Related]
35. Joint production of prime/boost pairs of Fowlpox Virus and Modified Vaccinia Ankara recombinants carrying the same transgene.
Soprana E; Panigada M; Knauf M; Radaelli A; Vigevani L; Palini A; Villa C; Malnati M; Cassina G; Kurth R; Norley S; Siccardi AG
J Virol Methods; 2011 Jun; 174(1-2):22-8. PubMed ID: 21419167
[TBL] [Abstract][Full Text] [Related]
36. Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity.
Kastenmuller W; Drexler I; Ludwig H; Erfle V; Peschel C; Bernhard H; Sutter G
Virology; 2006 Jul; 350(2):276-88. PubMed ID: 16595141
[TBL] [Abstract][Full Text] [Related]
37. [Insertion mutants of the vaccinia virus. The effect of inactivating E7R and D8L genes on the biological properties of the virus].
Chernos VI; Vovk TS; Ivanova ON; Antonova TP; Loparev VN
Mol Gen Mikrobiol Virusol; 1993; (2):30-4. PubMed ID: 8515749
[TBL] [Abstract][Full Text] [Related]
38. Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis.
Fischer SF; Ludwig H; Holzapfel J; Kvansakul M; Chen L; Huang DC; Sutter G; Knese M; Häcker G
Cell Death Differ; 2006 Jan; 13(1):109-18. PubMed ID: 16003387
[TBL] [Abstract][Full Text] [Related]
39. Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya.
Bejon P; Peshu N; Gilbert SC; Lowe BS; Molyneux CS; Forsdyke J; Lang T; Hill AV; Marsh K
Clin Infect Dis; 2006 Apr; 42(8):1102-10. PubMed ID: 16575727
[TBL] [Abstract][Full Text] [Related]
40. Recombinant viruses obtained from co-infection in vitro with a live vaccinia-vectored influenza vaccine and a naturally occurring cowpox virus display different plaque phenotypes and loss of the transgene.
Hansen H; Okeke MI; Nilssen O; Traavik T
Vaccine; 2004 Dec; 23(4):499-506. PubMed ID: 15530698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
